Guangdong Biolight Meditech Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jinyuan Yan
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.9yrs |
| CEO ownership | 27.0% |
| Management average tenure | no data |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Shares Bounce 39% But Its Business Still Trails The Industry
Oct 08
Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)
Jun 07Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge
Jun 06There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise
Mar 08CEO
Jinyuan Yan (61 yo)
13.9yrs
Tenure
CN¥1,790,400
Compensation
Mr. Jinyuan Yan has been a Director of Guangdong Biolight Meditech Co., Ltd since January 9, 2011 and serves as its Chairman and President.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & President | 13.9yrs | CN¥1.79m | 27.03% CN¥ 473.7m | |
| VP & Director | 11yrs | CN¥742.50k | 0.058% CN¥ 1.0m | |
| VP & Director | 2yrs | CN¥493.20k | 0.0096% CN¥ 168.8k | |
| Independent Director | 3.4yrs | CN¥120.00k | no data | |
| Independent Director | 2yrs | CN¥120.00k | no data | |
| Supervisor | 9.6yrs | no data | no data | |
| Supervisor | 11yrs | no data | no data | |
| Director | 4.6yrs | CN¥120.00k | no data | |
| Employee Supervisor | 3.5yrs | no data | no data | |
| Non-Independent Director | 2yrs | CN¥717.60k | no data | |
| Independent Director | 2yrs | CN¥120.00k | no data | |
| Director | 1.3yrs | CN¥30.00k | no data |
3.5yrs
Average Tenure
51yo
Average Age
Experienced Board: 300246's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 11:01 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Biolight Meditech Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Peng Zou | China International Capital Corporation Limited |
| Ling Bo Tu | China Minzu Securities |